Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Influenza A (H1N1) vaccine
- Development stage
- Approved
- Lead developer
- Sanofi Pasteur
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Intranasal
01
Overview
The influenza A (H1N1) vaccine is an inactivated or live attenuated viral vaccine developed to provide active immunization against the pandemic H1N1 2009 strain of the influenza virus. It works by stimulating the immune system to produce antibodies specific to the H1N1 virus hemagglutinin and neuraminidase antigens. The primary indication is prevention of infection and disease caused by the pandemic H1N1 2009 strain in individuals aged six months and older. Multiple formulations exist including split virion inactivated vaccines for intramuscular injection and live attenuated vaccines for intranasal administration. The development was a global effort involving several major pharmaceutical companies[2][3][5].
- Brand names
- AFLURIA
- Other names
- swine flu vaccine2009 H1N1 flu shot
02
Targets
N1 NA (Influenza A neuraminidase N1)
Beyond the preview
Go deeper on Influenza A (H1N1) vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Influenza A (H1N1) vaccine.